Product Information
APREPITANT 40 MG CAPSULE is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $46.4206 per EA under NDC 13668059182. Its NADAC has been published 293 times since Feb 24, 2021.
FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668059182
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
APREPITANTApproval Type
Generic (ANDA)
FDA Application
ANDA211835FDA Approved
10/21/2020
TE Code
AB
On Market Since
10/21/2020
Pharmacological Classes
Price Statistics
The NADAC for APREPITANT 40 MG CAPSULE has been published 293 times since Feb 24, 2021, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.4206 per EA |
|---|---|
| All-time high | $79.9243 (Apr 14, 2021) |
| All-time low | $34.4783 (Nov 20, 2024) |
| 52-week high | $47.4921 |
| 52-week low | $38.1856 |
| Median price | $57.8507 |
| Average price | $56.7531 |
| Largest weekly change | +42.7% (Feb 22, 2023) |
| Weeks tracked | 293 |
| Tracking since | Feb 24, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
APREPITANT market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Substance P/Neurokinin-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of APREPITANT 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APREPITANT 40 MG CAPSULE, manufactured by Torrent Pharmaceuticals Limited, is $46.4206 per EA (NDC 13668059182), effective Sep 30, 2026.
How has the price of APREPITANT 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APREPITANT 40 MG CAPSULE has declined 41.9%. It has been tracked across 293 weekly CMS publications since Feb 24, 2021.
What are the highest and lowest recorded NADAC prices for APREPITANT 40 MG CAPSULE?
Since Feb 24, 2021, the NADAC for APREPITANT 40 MG CAPSULE has ranged from a low of $34.4783 (Nov 20, 2024) to a high of $79.9243 (Apr 14, 2021), with a median of $57.8507 per EA.
Are there cheaper alternatives to APREPITANT 40 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as APREPITANT 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures APREPITANT 40 MG CAPSULE?
APREPITANT 40 MG CAPSULE (NDC 13668059182) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.